Marvel Biosciences Corp (MRVL : TSX-V)
Common Stock
$0.12
CAD
+0.00 (%)
Last updated: 2026-10-29
Follow MRVL
MRVL
Marvel Biosciences Corp
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+4.35%
1 Month
-22.58%
YTD
-11.11%
Key Statistics
Market Cap
$8.84M
52W High
$0.25
52W Low
$0.10
P/E Ratio
-
50 Day MA
$0.14
200 Day MA
$0.15
Beta
0.49
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/29/2026 | $0.13 | $0.13 | $0.12 | $0.12 | $0.12 | 5,569 |
| 10/28/2026 | $0.13 | $0.13 | $0.12 | $0.12 | $0.12 | 29,000 |
| 10/27/2026 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 85,605 |
| 10/26/2026 | $0.12 | $0.13 | $0.12 | $0.13 | $0.13 | 58,559 |
| 10/23/2026 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 30,833 |
| 10/22/2026 | $0.13 | $0.13 | $0.12 | $0.12 | $0.12 | 111,000 |
| 10/21/2026 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 2,109 |
| 10/20/2026 | $0.10 | $0.12 | $0.10 | $0.12 | $0.12 | 280,267 |
| 10/19/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 27,525 |
| 10/16/2026 | $0.10 | $0.11 | $0.10 | $0.10 | $0.10 | 58,039 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MRVL's historical volatility
30-Day Vol
113.9%
Annualized
90-Day Vol
93.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.11 | C$0.08 – C$0.17 |
| 60 trading days | C$0.11 | C$0.06 – C$0.19 |
| 90 trading days | C$0.10 | C$0.05 – C$0.20 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Marvel Biosciences Corp
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-2.19M
- Profit Margin
- 0.00%
- ROE (TTM)
- -380.30%
- EPS (Diluted)
- -0.03
- Book Value
- -0.04
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About MRVL
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| TNX | TenX Protocols Inc. | $49.89 | +49790.00% |
| CZZ | Cleghorn Minerals Ltd | $0.12 | +91.67% |
| MEGO-P | Amego Capital Corp. | $0.07 | +50.00% |
| SNV | Sonoro Energy Ltd | $0.01 | +50.00% |
| ESBL | Eshbal Functional Food Inc. | $0.07 | +40.00% |
| ALT | Alturas Minerals Corp | $0.02 | +33.33% |
| HANS | Hanstone Gold Corp | $0.02 | +33.33% |
| ILC | ILC Critical Minerals Ltd. | $0.02 | +33.33% |
MRVL.V news timeline
10 articles covering MRVL.V, most recent first
Latest